martes, 14 de octubre de 2014

National Guideline Clearinghouse | Octreotide for the management of neuroendocrine tumours.

full-text ►

National Guideline Clearinghouse | Octreotide for the management of neuroendocrine tumours.



CancerControl Alberta

National Guideline Clearinghouse (NGC)

Guideline Title

Octreotide for the management of neuroendocrine tumours.

Bibliographic Source(s)
Alberta Provincial Endocrine Tumour Team. Octreotide for the management of neuroendocrine tumours. Edmonton (Alberta): CancerControl Alberta; 2013 Nov. 16 p. (Clinical practice guideline; no. ENDO-003).  [46 references]

Guideline Status

This is the current release of the guideline.

No hay comentarios:

Publicar un comentario